TABLE 2.
The number of patients hospitalized in groups according to the International Classification of Diseases, 10th Revision (ICD‐10)
| Period | 18/Mar/2019–May 19, 2019 (n) | 14/Mar/2020–May 15, 2020 (n) | P value |
|---|---|---|---|
|
Diseases of the skin and subcutaneous tissue (XII)
L01‐L08 (Infections of the skin and subcutaneous tissue)
L10‐14 (Bullous disorders)
L20 (Atopic dermatitis)
L27 (dermatitis due to substances taken internally)
L20‐L30 (excl. L20 & L27) (Dermatitis and eczema)
L40 (Psoriasis)
L41 (Parapsoriasis)
L43‐L44 (Lichen planus & other papulosquamous disorders)
L50 (Urticaria)
L51 (Erythema multiforme)
L52‐L57 (Erythema nodosum, other erythematous conditions, erythema in diseases classified elsewhere, radiation‐related disorders of the skin and subcutaneous tissue)
L63 (alopecia areata)
L64‐L67 (Androgenic alopecia, other nonscarring hair loss, cicatricial alopecia, hair color, and hair shaft abnormalities)
L70‐L74 (Acne, rosacea, follicular cysts of skin and subcutaneous tissue, other follicular disorders, eccrine sweat disorders)
L85‐L91 (Other epidermal thickening, keratoderma in diseases classified elsewhere, transepidermal elimination disorders, pyoderma gangrenosum, decubitus ulcer and pressure area, atrophic disorders of skin, hypertrophic disorders of skin)
L92 (Granulomatous disorders of skin and subcutaneous tissue)
L93 (Lupus erythematosus, CLE)
L94 (Other localized connective tissue disorders)
L95 (Vasculitis limited to skin, not elsewhere classified)
L97‐L98 (Ulcer of lower limb, not elsewhere classified, other disorders of skin and subcutaneous tissue, not elsewhere classified) |
425 (67.9%)
4 (0.6%)
27 (4.3%)
34 (5.4%)
4 (0.6%)
70 (11.2%)
127 (20.3%)
11 (1.8%)
17 (2.7%)
12 (1.9%)
1 (0.1%)
7 (1.1%)
17 (2.7%)
13 (2.1%)
11 (1.8%)
13 (2.1%)
11 (1.8%)
10 (1.6%)
20 (3.2%)
11 (1.8%)
5 (0.8%) |
120 (68.2%)
2 (1.1%)
10 (5.7%)
1 (0.6%)
8 (4.5%)
6 (3.4%)
55 (31.3%)
1 (0.6%)
1 (0.6%)
7 (3.9%)
2 (1.1%)
3 (1.7%)
4 (2.3%)
2 (1.1%)
1 (0.6%)
4 (2.3%)
0 (0.0%)
1 (0.6%)
3 (1.7%)
1 (0.6%)
8 (4.5%) |
NS
NS
NS
.005
.0001
.0018
.002
NS
<.0001
NS
NS
NS
NS
NS
NS
NS
NA
NS
NS
NS
.0005 |
|
Certain infectious and parasitic diseases (I)
A46 (Erysipelas)
A51‐A54 (Early syphilis, late syphilis, other and unspecified syphilis, gonococcal infection)
A18.4 (Tuberculosis of skin and subcutaneous tissue)
B02 (Herpes zoster)
B35 (Dermatophytosis)
B86 (Scabies) |
35 (5.6%)
12 (1.9%)
11 (1.8%)
4 (0.6%)
5 (0.8%)
2 (0.3%)
1 (0.2%) |
18 (10.2%)
9 (5.1%)
8 (4.5%)
0 (0%)
0 (0%)
0 (0%)
1 (0.6%) |
.002
.019
.031
NA
NA
NA
NS |
|
Neoplasms (II)
C84‐C85 (Mature T/NK‐cell lymphomas, Other and unspecified types of non‐Hodgkin lymphoma)
C44 (Other malignant neoplasms of skin)
D22 (Melanocytic nevi)
D23 (Other benign neoplasms of skin) |
98 (15.7%)
13 (2.1%)
63 (10.1%)
9 (1.4%)
13 (2.1%) |
25 (14.2%)
9 (5.1%)
12 (6.8%)
1 (0.6%)
3 (1.7%) |
NS
.029
NS
NS
NS |
|
Diseases of the eye and adnexa (VII) H02 (Other disorders of eyelid) |
27 (4.3%) | 1 (0.6%) | .017 |
|
Diseases of the musculoskeletal system and connective tissue (XIII)
M30‐M36 (Systemic connective tissue disorders) |
14 (2.2%) | 8 (4.5%) | NS |
|
Congenital malformations, deformations and chromosomal abnormalities (XVII)
Q80 (Congenital ichtyosis)
Q 82.2 (Mastocytosis)
Q85 (Phakomatoses) |
17 (2.7%)
2 (0.3%)
12 (1.9%)
3 (0.5%) |
1 (0.6%)
0 (0.0%)
1 (0.0%)
0 (0.0%) |
NS
NA
NS
NA |
| Others | 10 (1.6%) | 3 (1.7%) | NS |
| Endocrine, nutritional, and metabolic diseases (IV) | |||
| Diseases of the nervous system (VI) | |||
| Diseases of the circulatory system(IX) | |||
| Diseases of the digestive system (XI) | |||
| Diseases of the genitourinary system (XIV) | |||
| Factors influencing health status and contact with health services (XXI) |
Abbreviations: NS, not significant, NA, not applicable.